Categories AlphaGraphs, Earnings, Health Care
Earnings: Highlights of Eli Lilly & Company’s (LLY) Q1 2023 results
Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for fiscal 2023.
The Indianapolis-based pharmaceutical company said its revenues declined 11% year-over-year to $6.96 billion in the first quarter, hurt by lower realized prices and a decline in volumes.
The weak top-line performance translated into a 38% fall in net earnings, on an adjusted basis, to $1.62 per share. Unadjusted profit decreased to $1.34 billion or $1.49 per share from $1.90 billion or $2.10 per share in the first quarter of 2022.
“Core business growth drove solid first-quarter financial results and a strong start for Lilly in 2023, which includes pipeline progress led by positive SURMOUNT-2 data for tirzepatide in obesity,” said David Ricks, CEO of Eli Lilly.
Prior Performance
Most Popular
Will Domino’s (DPZ) continue its earnings-beat streak in Q4 2024?
Domino’s Pizza, Inc. (NYSE: DPZ) has remained largely unaffected by economic uncertainties and spending constraints, by offering value through its innovative discount program and attracting price-conscious diners. The company expects
What to look for when Home Depot (HD) reports Q4 2024 earnings results
Shares of Home Depot (NYSE: HD) have gained 13% over the past 12 months. The home improvement retailer is scheduled to report its earnings results for the fourth quarter of
Earnings Summary: Highlights of Airbnb’s (ABNB) Q4 2024 results
Accommodation booking platform Airbnb Inc (NASDAQ: ABNB) has reported a profit for the fourth quarter of 2024, compared to a loss in the year-ago quarter. Fourth-quarter revenue increased 12% annually